Acceptance and preference between respiratory syncytial virus vaccination during pregnancy and infant monoclonal antibody among pregnant and postpartum persons in Canada

Abstract

BACKGROUND: Vaccination during pregnancy and infant monoclonal antibodies (mAb) were recently approved to prevent respiratory syncytial virus (RSV) disease in infants. Our study aims to describe self-reported attitudes and preferences between vaccination during pregnancy and infant mAb for this indication. METHODS: From September 2023-March 2024, we completed a web-based, cross-sectional survey within the COVERED national prospective cohort …

Authors

McClymont E; Wong JMH; Forward L; Blitz S; Barrett J; Bogler T; Boucoiran I; Castillo E; D'Souza R; El-Chaâr D

Journal

Vaccine, Vol. 50, ,

Publisher

Elsevier

Publication Date

March 2025

DOI

10.1016/j.vaccine.2025.126818

ISSN

0264-410X

Associated Experts

Rohan D'Souza

Associate Professor, Faculty of Health Sciences

Visit profile

Labels